Clinical Trial Update: Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 translational study of nivolumab in combination with bevacizumab for recurrent glioblastoma. The trial has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Avastin (bevacizumab)
• OPDIVO (nivolumab)

Snippet

Sponsor: Ulrik Lassen | Conditions: Recurrent Adult Brain Tumor | Phase 2 | Status: COMPLETED